Alyeska Investment Group, L.P.

Position in RGC — Regencell Bioscience Holdings Ltd

CIK 1453072 CHICAGO, IL

Position in RGC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,535,029

New position

Shares Held

416,261

first reported quarter

Ownership

0.084%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#2

of 35 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $270,329,085 across 4 Drug Manufacturers - Specialty & Generic names. RGC ranks #4 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	6,257,579	$212,006,776
2	ELAN	Elanco Animal Health Inc	1,498,380	$36,875,131
3	AMLX	Amylyx Pharmaceuticals, Inc.	1,053,015	$18,912,149
4	RGC	Regencell Bioscience Holdings Ltd This page	416,261	$2,535,029

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,535,029	416,261	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.